SISXF (Savaria) ROCE % : 9.34% (As of Dec. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Savaria ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Savaria's annualized ROCE % for the quarter that ended in Dec. 2024 was 9.34%.

Savaria ROCE % Historical Data

The historical data trend for Savaria's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Savaria ROCE % Chart

Savaria Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

10.26

4.82

6.63

7.97

8.78

Savaria Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															8.66	8.23	8.53	9.60	9.34

Savaria ROCE % Calculation

Savaria's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	59.236	/	( ( (821.089 - 127.119)	+	(782.066 - 126.165) )	/ 2 )
	=	59.236	/	( (693.97	+	655.901)	/ 2 )
	=	59.236	/	674.9355
	=	8.78 %

Savaria's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	63.588	/	( ( (832.236 - 126.937)	+	(782.066 - 126.165) )	/ 2 )
	=	63.588	/	( ( 705.299	+	655.901 )	/ 2 )
	=	63.588	/	680.6
	=	9.34 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

Savaria (OTCPK:SISXF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Savaria ROCE % Related Terms

Thank you for viewing the detailed overview of Savaria's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Savaria Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Savaria Corp (OTCPK:SISXF) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

S97:Germany SIS:Canada

Address

4350 Highway 13, Laval, QC, CAN, H7R 6E9

Website

https://www.savaria.com

Savaria Corp designs, engineers, and manufactures products for personal mobility. Its products include home elevators, wheelchair lifts, commercial elevators, ceiling lifts, stairlifts, and van conversions. The company's operating segments are Accessibility, Patient Care, and Adapted Vehicles. The Accessibility segment deals with manufacturing, designing, installing, and distributing elevators, platform lifts, and stairlifts for people with mobility challenges. The Adapted Vehicle segment adapts vans to be wheelchair accessible for people with mobility challenges. The Patient Care segment includes the manufacturing and distribution of a comprehensive line of therapeutic support surfaces and other pressure management products for the medical market.